In this study, aiming to unravel the molecular mechanisms of anti‐VEGF‐A treatment in psoriasis skin ex vivo, we investigated the early transcriptomic changes induced by bevacizumab in organ‐cultured psoriasis plaque and non‐lesional skin. This evidence concerns the gene VEGFA and psoriasis.